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Abstract
Objective: To check compliance of anaesthetist to current policies set for the use of medication within operation
room and for induction room floor stock.
Methods: The initial audit was conducted from 1st October to 31st November 2006 and reaudit after
dissemination and sharing of results within the department repeated in July-August 2007. In each audit four
operating rooms were visited twice a week. Syringes were checked for standard drug labelling for narcotic and
non narcotic preparations. Drug trolley was checked for any expired drugs and whether the trolley was locked in
case of operating room (OR) where list was ended or was on hold. Any unattended drug was noted and Induction
room was checked twice weekly for accurate drug inventory and for standard drug storage recommendations. 
Results: Labels were according to standard in non narcotic drugs on 25% syringes in first audit and 63% in
second audit, likewise, narcotics labels were according to standards in 41 % in first and 57% in second audit.
Unattended drugs were present once in first and twice in second audit. There was 100% compliance in other
drug storage policy parameters in both audits. 
Conclusion: Poor compliance of drug labelling standards for both narcotic and non narcotic drugs was present.
However, second audit revealed improvement in all areas of drug handling. Dissemination of policies and
reminders are important for continuing improvement in use of medication within operation room and within
induction room floor stock (JPMA 59:825; 2009).
Introduction
Anaesthesia involves frequent injection of potent
intravenous drugs. These drugs are often prepared and drawn
up in syringes some time before they are to be used. The
potential of a wrong drug being given because of syringe swap
or wrong dilution of drugs is a real possibility. Majority of
these drug errors are totally or partially attributed to human
error.1 Reports on drug error in anaesthesia have addressed the
issue of colour coding of ampoules and syringe labels. The
addition of colour to a label is thought to be an additional
visual and psychological cue for choosing the right ampoule
or syringe.1 A previous published report from our department
has documented drug errors to be 21% of total reported critical
incidents.2 In order to reduce these errors standardized drug
labelling and storage was introduced in July 2006, which was
in line with current international standards.3
The objective of this current audit was to check
compliance of anaesthetist to current policies set for the use of
medication within the operating room and for induction room
floor stock.
Methods
In each audit four operation rooms were visited twice
a week. Syringes were checked for standard drug labelling for
narcotic and non narcotic preparations. Standards that were
used as a bench mark were as follows: Drug labels on syringes
should clearly state name of drugs with concentration and time
of preparation, narcotic syringe should be labelled with patient
identity, any drug expired as per manufacturer
recommendation should not be present on the drug trolley,
drug trolleys should be locked in between cases and no
unattended medication should be present on the drug trolley in
the absence of anaesthetist in the operating room.
In addition, standards applied to the floor stock kept in
the induction room were; floor stock should be same as
documented in the file, no expired drugs should be present in
the drug storage and temperature of refrigerator used in the
induction room should be at 4 degrees centigrade.
The initial audit was conducted between 1st October to
31st November 2006. 
Following methodology was used. Our main
operating room suite has eleven operating room (ORs). Two
sets of operating rooms were selected randomly one in which
a surgical case was in progress and another where list was on
hold. These operating rooms were visited by one of the
investigator between 8am-5 pm. Randomization was
achieved by assigning a number on a piece of paper for each
OR. Four papers were then picked up by the investigator.
Four operating rooms were visited by the principal
investigator or co-investigators depending on the
availability. The selected days of audit were also randomly
selected by picking four pieces of paper. Timing of audit was
not standardized and left to investigators convenience. A
specially designed form was used. 
The following was checked:
1. In each operating room where a case was in progress
a check was observed whether drug labels on syringes were
written according to department guidelines, narcotics syringes
were labelled with patient identity and if any, expired
anaesthesia drugs were present. Labels which were found
deficient in any component were regarded as incomplete. 
2. Checklist in empty operating room included
whether drug trolley was locked or unlocked and if any
unattended drugs were present.
3. The induction room refrigerator was checked for its
temperature (four degree centigrade), whether it was locked or
not, presence of inappropriate items like food, blood etc, any
unauthorized drug present, any expired drug present or not and
for correct number of drugs present as documented. 
4. Induction room drug cupboard was checked
whether it was locked, total number of documented drugs
present, bins of drugs with proper labels present and for
presence of any expired drugs. 
Any part of missing standard such as name or
concentration was taken as non compliance.
Results of these audits were disseminated in the
department at different levels. A re-audit based on the same
methodology was conducted between 1st July till 31st
August 2007.
Results
In the initial audit, 58 operating rooms audited were in
progress and 8 were on hold. On 16 occasions induction room
was inspected. Out of the operating rooms in which a case was
in progress, only 15% were compliant with proper drug
labelling whereas compliance for the presence of patient
identity on narcotic syringes was 24% (Table-1). Unattended
drug was found only once. In induction room refrigerator was
found to be unlocked on only one occasion as drug was taken
just before inspection. 
In the re-audit, 57 operating rooms were in progress
and seven were on hold. There was compliance with proper
labelling in 63% drug preparations; compliance with patient
ID stickers was 57% on narcotic syringes. Unattended drugs
were found on two occasions. In induction room refrigerator
was found to be unlocked on 3 occasions (Table-2). There
was 100% compliance in other drug storage policies
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Table-1: Drug standards compliance inside operational
operating rooms during the two audits.
Standard Oct-Nov 2006 July-Aug 2007
Drug labels according to
department standards 15 (25.8%) 36 (63.1%)
Expired drug present in No expired drug No expired drug
anaesthesia trolley present present
Narcotics labelled with
patient identity 24 (41.3%) 33 (57.8%)
Table-2: Compliance of drug standards in operating rooms on hold.
Standard Oct-Nov 2006 July-Aug 2007
Drug trolley locked 3 (50%) 6 (85.7%)
Unattended drugs present 1 (20%) 2 (28.5%)
Names of unattended drugs Lignocaine P h e n y l e p h e r i n e ,
GTN
Table-3: Compliance of drug standards in Induction room
for drugs in refrigerator in both audits.*
Standard Compliance
Refrigerator locked 16 (100%)
Temperature of refrigerator is within range 16 (100%)
Inappropriate items like food, blood etc. present or not? 0 (0.0%)
Unauthorized drug present or not? 0 (0.0%)
Expired drug present or not? 0 (0.0%)
Correct number of drugs present as documented 16 (100%)
*Result was same in both audits.
parameters in both audits (Table-3). 
Discussion
Drug related incidents are a common form of reported
medical errors. The importance of drug error has been
emphasized in the Harvard Medical Practice Study,4 the
Quality in Australian Healthcare Study5 and a report from the
U.S. Institute of Medicine.6 In the Australian study, drug errors
were the fourth commonest category of adverse events
(accounting for 10.8%), resulting in permanent disability in
17% and death in 8%. The reduction of iatrogenic harm has
been recognized as a priority in healthcare.5 It is important to
understand that iatrogenic harm is not a homogeneous
problem, but is contributed to by deficiencies in the system in
which medical professionals work.
Drug administration error in anaesthesia is an
important subset of drug error in general. Most of the errors
reported in anaesthesia practice are preventable.2 Serious
morbidity and mortality resulted from clearly preventable
events.7 In a survey conducted in New Zealand problems with
drug labels were contributing factors with 9% of error
reports.8 In a study of 55,426 anaesthetics in Norway , drug
error was reported in 63 or 0.11% of cases over 36 months.9
In a study of 896 drug errors reported in Australia, 187
(20.8%) involved selecting the wrong ampoule or making an
error in drug labelling.10 Contributing factors included
inattention, haste, drug-labelling error, communication failure,
and fatigue. Factors minimizing the events included prior
experience and training. A survey among obstetric
anaesthetist, responders put importance of drug labels on top
for preventing drug related incidents.11 The use of class-
specific colour coding for syringe and ampoule labels might
not reduce intra-class substitution, but would have
considerable potential for reducing inter-class errors.12,13 In
our institution (AKUH) 768 critical incidents were reported,
between January 1997 to December 2002, 165 (21%) of
which were related to drug errors. Under dosage, side-effect,
drug reaction and syringe swap were the most common. A
total of 76% were classified as preventable; 56% due to
human error and 19% due to system error.2 Considering a
large contribution of drug labels in drug related errors,
literature therefore supports the development of improved
standards for drug labels and the establishment of a reporting
programme for medication errors.14
Simple maneuvers like proper drug labeling, handling
and storage simply can reduce the risk and improves quality of
anaesthetic care. A standardized color code for user-applied
syringe labels for anaesthetic drugs exists in the USA,
Australia, New Zealand, South Africa, Canada and UK.
Considering these facts standardized syringe color labels
coding as approved by Association of Anaesthetists of Great
Britain and Ireland were introduced in our department in July
2006.3 The other standards used within the department are in
compliance with Joint Commission International
Accreditation (JCIA) standards.15
There should be a safe and secure storage arrangement
for all drugs in the operating rooms. Controlled substances
must be stored under lock when not in immediate use. A drug
inventory log book documenting use and remaining balance
should be in place for controlled drugs. Operating rooms
should have a documented policy to check that drugs and
supplies have not expired. The key to this drug safe must be
kept in a secure place away from the drug storage safe. We
found satisfactory compliance of policies in drug inventory
and storage. 
Audit is a process of quality control; in medicine it is
taken as systemic peer review in a clinical practice with the
object of maintaining and improving quality of that practice.
Regular audits to determine practice of these guidelines are
necessary in order to reduce drug related critical incidents.
Our initial audit depicted lapses in compliance of drug policy
specially in labelling of drugs. Drug labelling and handling
policy was properly communicated at different fora within the
department to disseminate awareness. The second audit
conducted after six months, a replicate of previous audit was
carried out for the same purpose. Looking at results of both
audits it is seen that there is general improvement in drug
handling. This shows the importance of auditing, feedback
and improving the practices.
This audit revealed poor drug standard compliance
especially in drug preparation, however there was excellent
drug compliance in drug storage standards. In addition this
audit also revealed importance of propagation and
dissemination of policies in general improvement in all of the
areas of drug handling but there is still a lot of room for further
improvement. Propagation of information especially among
the new staff and constant reminders are important for
persistent policy practice and reducing drug errors. In future
drug standard policies would be circulated regularly and
checked by mini audits. Drug related incidents would be
followed as part of our quality improvement measures and
their magnitude and importance discussed to guide us to
further develop these standards.
Conclusion
An audit was conducted to observe compliance of
departmental drug labeling and storage policies. Marked
improvement was observed in the next audit revealing
importance of education and information of hospital guidelines. 
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